Urologists are investigating the role of robotics, justice, exercise and medicine in bladder cancer

Urologists are investigating the role of robotics, justice, exercise and medicine in bladder cancer


NEW ORLEANS, May 14, 2022 / PRNewswire / – Do socioeconomic differences have an impact on the care of bladder patients? Can exercise improve the health of bladder cancer patients during treatment? What technological and pharmacological advances does urologists use to treat bladder cancer?

Urologists are investigating the role of robotics, justice, exercise and medicine in bladder cancer.

The researchers will present these results of a bladder cancer study at number 117thu Annual Scientific Meeting of the American Urological Association (AUA). Benjamin DaviesMD, Professor of Urology at the UK University of Pittsburgh The School of Medicine and Director of the Urological Oncology Program at Shadyside / Hillman Cancer Center will moderate a press session with the following four abstracts at the Ernest N. Morial Convention Center in New Orleans on May 14, 2022in 11:00 Thu..

Boris GershmanMUDr, at Beth Israel Deaconess Medical Center, investigated socioeconomic differences and their potential impact on the treatment of non-invasive bladder cancer (NMIBC) despite strict clinical practice guidelines. “Differences in the prevalence and treatment of high-risk non-muscular invasive bladder cancer”

Not much is known about the effect of patient behavior on bladder cancer Mara KoelkerMUDr, at Brigham and Women’s Hospital, investigated the role of exercise in their own physical condition. “The effect of exercise on physical health in patients with bladder cancer”

Pramit KhetrapalMUDr, at University College London, explored the use of intracorporeal robot-assisted RC (iRARC) vs. open RC (ORC) and the impact on the recovery time of a patient with bladder cancer. “Results of a multicenter randomized intracorporeal Robotic versus Open Cystectomy (iROC) study”

According to the Icahn School of Medicine at Mount Sinai’s, disease-free survival was significantly improved with adjuvant nivolumab compared to placebo in patients with high-risk muscle-invasive urothelial carcinoma (MIUC) after radical surgery. Matěj GalskýMUDr. “Disease-free survival with longer follow-up from the CheckMate 274 study with adjuvant nivolumab in patients after surgery for high-risk muscle-invasive urothelial carcinoma”

“The bladder cancer session highlights technological and pharmacological advances in bladder cancer care, as well as important work on equality and exercise,” said Dr. Davies.

About the American Urological Association: 117thu The annual meeting of the American Urological Association is held 13-16 May at the Ernest N. Morial Congress Center in New Orleans. The company was founded in 1902 and is headquartered near Baltimore. MarylandThe American Urological Association is a leading proponent of urology and has nearly 24,000 members worldwide. The AUA is a leading urology association that provides invaluable support to the urology community in fulfilling its mission to promote the highest standards of urology through education, research, and health policy formulation.

Media Contact:
Caitlin LukacsCorporate Communications and Media Relations Manager
410-689-4081, clukacs@auanet.org

American Urological Association (PRNewsFoto / American Urological Association)

Cision

View original multimedia downloads: https://www.prnewswire.com/news-releases/urologists-explore-the-role-of-robotics-equity-exercise-and-medicine-on-bladder-cancer-301546820. html

SOURCE American Urological Association



Source link

Leave a Comment

Your email address will not be published.

Exit mobile version